USD 1.55
(5.44%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.4 Million USD | -34.7% |
2022 | 3.68 Million USD | -24.26% |
2021 | 4.85 Million USD | -26.51% |
2020 | 6.61 Million USD | 3300.24% |
2019 | 194.46 Thousand USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 360 Thousand USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 2.06 Million USD | 0.0% |
2024 Q2 | 2.7 Million USD | 0.0% |
2024 Q3 | 1.37 Million USD | -49.0% |
2023 Q2 | 3.05 Million USD | -9.42% |
2023 Q4 | 2.4 Million USD | -11.99% |
2023 Q3 | 2.73 Million USD | -10.52% |
2023 Q1 | 3.36 Million USD | -8.47% |
2023 FY | 2.4 Million USD | -34.7% |
2022 Q3 | 3.98 Million USD | -6.92% |
2022 FY | 3.68 Million USD | -24.26% |
2022 Q1 | 4.57 Million USD | -5.92% |
2022 Q4 | 3.68 Million USD | -7.59% |
2022 Q2 | 4.27 Million USD | -6.4% |
2021 Q3 | 5.13 Million USD | -14.13% |
2021 Q4 | 4.85 Million USD | -5.42% |
2021 FY | 4.85 Million USD | -26.51% |
2021 Q1 | 6.35 Million USD | -3.83% |
2021 Q2 | 5.98 Million USD | -5.92% |
2020 FY | 6.61 Million USD | 3300.24% |
2020 Q4 | 6.61 Million USD | -16.77% |
2020 Q3 | 7.94 Million USD | 16.6% |
2020 Q2 | 6.81 Million USD | -3.89% |
2020 Q1 | 7.08 Million USD | 3545.45% |
2019 FY | 194.46 Thousand USD | 0.0% |
2019 Q4 | 194.46 Thousand USD | 0.0% |
2019 Q2 | 184.3 Thousand USD | 0.0% |
2019 Q3 | - USD | -100.0% |
2019 Q1 | 184.3 Thousand USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q1 | 360 Thousand USD | 0.0% |
2018 Q2 | 328.98 Thousand USD | -8.61% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | -100.0% |
2017 Q4 | 360 Thousand USD | 0.0% |
2017 FY | 360 Thousand USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
China Pharma Holdings, Inc. | 1.41 Million USD | -70.218% |
cbdMD, Inc. | 2.4 Million USD | 0.0% |
Zomedica Corp. | 1.81 Million USD | -32.485% |